Clinical Development Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Clinical Development stocks.

Clinical Development Stocks Recent News

Date Stock Title
May 7 NVAX Novavax top investor calls for removal of three company directors
May 7 SAGE Sage Therapeutics to Participate in Upcoming May Investor Conferences
May 6 NVAX Novavax stock breaks six-day winning streak
May 6 NVAX UPDATE 5-Shah Capital urges Novavax shareholders to vote against three directors
May 6 LXRX Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q1 2024 Earnings Call Transcript
May 6 MCRB Seres Therapeutics to Announce First Quarter 2024 Financial Results and Business Update on May 8, 2024
May 6 NVAX Novavax's top shareholder Shah Capital ramps up efforts for board shakeup
May 6 BLRX BioLineRx Announces Poster Presentation on Economic Model Data for APHEXDA® (motixafortide) as part of CD34+ Hematopoietic Stem Cell Mobilization in Patients with Multiple Myeloma at ISPOR 2024
May 6 NVAX UPDATE 2-Novavax's top shareholder Shah Capital ramps up efforts for board shakeup
May 6 NVAX Shah Capital Launches Campaign Urging Stockholders to Vote AGAINST the Re-Election of All of Novavax’s Directors Up for Election at its 2024 Annual Meeting
May 5 LXRX Lexicon Pharmaceuticals, Inc. (LXRX) Q1 2024 Earnings Call Transcript
May 3 LXRX Q1 2024 Lexicon Pharmaceuticals Inc Earnings Call
May 3 LXRX Lexicon Pharmaceuticals Inc (LXRX) Q1 2024 Earnings Call Transcript Highlights: Navigating ...
May 2 LXRX Lexicon Pharmaceuticals (LXRX) Reports Q1 Loss, Misses Revenue Estimates
May 2 LXRX Lexicon Pharmaceuticals Reports Q1 2024 Earnings: Aligns with EPS Projections Amidst Strategic ...
May 2 NKTR Nektar to Announce Financial Results for the First Quarter 2024 on Thursday, May 9, 2024, After Close of U.S.-Based Financial Markets
May 2 LXRX Lexicon Pharmaceuticals GAAP EPS of -$0.20 in-line, revenue of $1.13M misses by $0.27M
May 2 LXRX Lexicon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
May 2 ONCT Oncternal Therapeutics to Provide Business Update and Report First Quarter 2024 Financial Results
May 1 LXRX Lexicon Pharmaceuticals Q1 2024 Earnings Preview
Clinical Development

Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.

Browse All Tags